SCHEMBL5206883

SCHEMBL5206883

Nc1ncc(Cc2ccc(C(F)(F)F)cc2)c(N2CCC(=O)CC2)n1

nearest known ligand 0.58

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.43
TRAP1 Q12931 1/20 0.42
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
RPS6KB1 P23443 1/20 0.38
SMO Q99835 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202458 0.87 DHFR (0.48) DHFR
SCHEMBL5204379 0.85 DHFR (0.37) DHFR
SCHEMBL5205280 0.85 DHFR (0.45) DHFRPIK3CA
SCHEMBL5203003 0.85 DHFR (0.40) DHFR
SCHEMBL5204607 0.85 DHFR (0.40) DHFR
SCHEMBL5202937 0.84 TRAP1 (0.42) DHFRTRAP1PIK3CAPIK3CB
SCHEMBL7157196 0.81 RPS6KB1 (0.43) RPS6KB1SMO
SCHEMBL7714161 0.81 DHFR (0.44) DHFRRPS6KB1
SCHEMBL7714159 0.81 DHFR (0.42) DHFRRPS6KB1
SCHEMBL7458908 0.77 RPS6KB1 (0.42) RPS6KB1SMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed